One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."

But there's a much better move you can make to get in front of these big moves today.

Thomas Haughey Biography and Net Worth

Director of ANI Pharmaceuticals

Mr. Haughey has been a member of the Board since May 2018. Mr. Haughey held the role of General Counsel and Secretary at Par Pharmaceutical Companies, Inc. (“Par”) from 2003 through 2016. In addition to his role as General Counsel, he has held various additional executive roles at Par including President from 2011 to 2012 and, most recently, Chief Administrative Officer from 2012 to 2016. Prior to that, Mr. Haughey held positions at Schering-Plough Corporation, where he was Chief Counsel from 1998 to 2001 and Legal Director from 2001 to 2003. Previously, Mr. Haughey was an attorney at Cadwalader Wickersham & Taft and a certified public accountant at Arthur Anderson & Co. Mr. Haughey earned a B.S. in accounting at St. John’s University and a J.D. at the New York University School of Law.

What is Thomas Haughey's net worth?: The estimated net worth of Thomas Haughey is at least $535,432.78 as of March 3rd, 2020. Mr. Haughey owns 8,291 shares of ANI Pharmaceuticals stock worth more than $535,433 as of April 19th. This net worth evaluation does not reflect any other investments that Mr. Haughey may own. Learn More about Thomas Haughey's net worth.
How do I contact Thomas Haughey?: The corporate mailing address for Mr. Haughey and other ANI Pharmaceuticals executives is 210 Main Street West, Baudette MN, 56623. ANI Pharmaceuticals can also be reached via phone at (218) 634-3500 and via email at [email protected]. Learn More on Thomas Haughey's contact information.
Has Thomas Haughey been buying or selling shares of ANI Pharmaceuticals?: Thomas Haughey has not been actively trading shares of ANI Pharmaceuticals in the last ninety days. Most recently, on Monday, December 6th, Thomas Haughey bought 2,500 shares of ANI Pharmaceuticals stock. The stock was acquired at an average cost of $39.38 per share, with a total value of $98,450.00. Learn More on Thomas Haughey's trading history.
Who are ANI Pharmaceuticals' active insiders?: ANI Pharmaceuticals' insider roster includes Stephen Carey (CFO), Thomas Haughey (Director), Nikhil Lalwani (Pres), Muthusamy Shanmugam (Head of R&D and COO), Jeanne Thoma (Director), and Patrick Walsh (Director). Learn More on ANI Pharmaceuticals' active insiders.
Are insiders buying or selling shares of ANI Pharmaceuticals?: During the last year, insiders at the specialty pharmaceutical company sold shares 44 times. They sold a total of 778,234 shares worth more than $45,770,310.97. The most recent insider tranaction occured on April, 17th when COO Muthusamy Shanmugam sold 9,520 shares worth more than $622,608.00. Insiders at ANI Pharmaceuticals own 12.7% of the company. Learn More about insider trades at ANI Pharmaceuticals.
Information on this page was last updated on 4/17/2024.

Thomas Haughey Insider Trading History at ANI Pharmaceuticals

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/6/2021	Buy	2,500	$39.38	$98,450.00
3/3/2020	Buy	2,000	$45.18	$90,360.00	8,291
5/15/2019	Buy	2,500	$69.30	$173,250.00	6,291

Thomas Haughey Buying and Selling Activity at ANI Pharmaceuticals

ANI Pharmaceuticals Company Overview

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Today's Range

Now: $65.48

$64.20

$65.78

50 Day Range

MA: $64.77

$55.02

$69.69

2 Week Range

Now: $65.48

$36.99

$70.81

Volume

93,623 shs

Average Volume

138,084 shs

Market Capitalization

$1.38 billion

P/E Ratio

77.95

Dividend Yield

N/A

Beta

0.79

Strange new buyer driving up gold

From Stansberry Research | Ad